In HelloNation, Health Insurance Expert David Wiley Explains Georgia Life Insurance Options for Families

The article outlines how term and permanent life insurance differ in cost, coverage length, and long-term financial planning. WATKINSVILLE, Ga., July 13, 2026 /PRNewswire/ -- How can families in Georgia decide between term life insurance and permanent life insurance? Licensed insurance...

As Ebola Spreads in Two More Provinces, NanoViricides Has Received ...

(PR-inside.com) SHELTON, CT / ACCESS Newswire / July 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces that it has received National Ethics Committee approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for the Current Bundibugyo Ebolavirus in the Democratic Republic of Congo (DRC). The Company is now getting ready to file a Clinical Trial Application to ACOREP, the regulatory agency in DRC. NanoViricides has already put together a team with a renowned Principal Investigator and with support from a well known University in ..

As Ebola Spreads in Two More Provinces, NanoViricides Has Received National Ethics Committee Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in Congo

Patel Orthopedics in Beverly Hills Advances Whole-Patient Orthopedic Care With Integrated Surgical, Regenerative, and Recovery Solutions

Under the leadership of dual board-certified orthopedic surgeon Dr. Rajan M. Patel, the Beverly Hills practice combines robotic-assisted surgery, regenerative therapies, and advanced recovery technologies in a unified care model designed to restore function, mobility, and long-term...

iFabric Corp. Announces Launch of Aura Scrubs at U.S. National Mass ...

(PR-inside.com) Third major retailer to adopt IFTNA's technology-enhanced scrub platform New Brand Expands Commercial Reach of PROTX2® and ecoPEL™, the Company's Proprietary Antimicrobial and Durable Water Repellant Technologies MARKHAM, ON / ACCESS Newswire / July 13, 2026 / iFabric Corp. ("iFabric" or the "Company") (TSX:IFA)(OTCQX:IFABF) is pleased to announce that its wholly owned subsidiary, Intelligent Fabric Technologies (North America) Inc. ("IFTNA"), is launching Aura, a new performance medical apparel scrubs line developed, branded, and manufactured by IFTNA, in cooperation with a leading U.S. national mass retailer. The Aura scrubs collection is launching in approximately 400 brick-and-mortar stores across the United States, together with availability ..

U.S. Food and Drug Administration Accepts BioMarin's Supplemental New Drug Application for Full Approval of VOXZOGO® (vosoritide) for Children With Achondroplasia

Application based on long-term safety and efficacy data from three ongoing studies, including adult height and additional clinical outcomes beyond linear growth, including body proportionality and arm span evaluated over long-term follow-up FDA PDUFA target action date of Feb. 28, 2027...

Health Insurance Private Plans Reach Households Above the Subsidy Line ...

(PR-inside.com) Health Insurance Now offers private options to middle-income families squeezed by the 2026 subsidy cliff. BOCA RATON, FL / ACCESS Newswire / July 13, 2026 / Health Insurance Now is reaching middle-income households hit hardest by the 2026 changes to health insurance subsidies, a group earning just above the eligibility threshold that has left the Marketplace in disproportionate numbers. For these families,health insurance private planshave become the practical path to coverage once premium tax credits fall away. Reporting on early 2026 enrollment found that people with incomes between 400 percent and 500 percent of the federal poverty level accounted for about 27 ..

Bavarian Nordic’s Chikungunya Vaccine Submitted for Regulatory Approval in Brazil

COPENHAGEN, Denmark, July 13, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced that its partner, Eurofarma, has submitted a marketing authorization application to the Brazilian Health Regulatory Agency (Anvisa) for Bavarian Nordic’s chikungunya vaccine, CHIKV VLP, for the prevention of disease caused by chikungunya virus in individuals 12 years of age and older.

Cadrenal Therapeutics’ Late-Breaking Phase 2 Data Demonstrate Greater Than 25% Reduction in Thrombotic Events in HIT for First-in-Class 12-LOX Inhibitor CAD-1005 at ISTH 2026 Congress

PARIS, July 13, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company advancing novel therapies for rare immunothrombotic conditions, announced today that late-breaking clinical data from the Phase 2 study of the first-in-class 12-lipoxygenase (12-LOX) inhibitor CAD-1005 were featured in a highly anticipated late-breaking oral presentation at the International Society on Thrombosis and Haemostasis (ISTH) 2026 Congress in Paris.

Health Insurance Private Plans Reach Households Above the Subsidy Line

Health Insurance Now offers private options to middle-income families squeezed by the 2026 subsidy cliff.

Magna Legal Services and Naegeli Deposition & Trial Combine to Expand Presence in the Pacific Northwest

Magna Legal Services, a nationwide leader in court reporting, medical record retrieval, litigation consulting, investigations and service of process, has combined with Naegeli Deposition & Trial. The transaction became effective on Thursday, July 9 and was led by John Brownschidle, Head...

Omada Health to Participate in Canaccord Genuity’s 46th Annual Growth Conference

Omada Health (Nasdaq: OMDA) announced that members of senior management will participate in Canaccord Genuity’s 46th annual Growth Conference.